12:00 AM
 | 
Feb 13, 2012
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Cadence sales and marketing update

Cadence recalled lot V005710 of Ofirmev IV acetaminophen in the U.S. due to the detection of an unidentified, visible particle in one vial during...

Read the full 109 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >